Trevi Therapeutics TRVI
NASDAQ TRVI
$14.18 -0.14 (-0.98%)
At close: Oct 1, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Shares Outstanding (Entity) (2018 - 2026)

Updated

Trevi Therapeutics' Shares Outstanding (Entity) came in at 142.42 million for Q2 2026, up 17.0% from 121.78 million a year earlier and up 10.9% from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends

For FY2025, Trevi Therapeutics' Shares Outstanding (Entity) was 128.31 million, up 37.1% from FY2024.

  • Shares Outstanding (Entity) carries a five-year compound annual growth rate of 47.2% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 93.6 million in FY2024 (-5.5%), 99.03 million in FY2023 (+65.2%), 59.94 million in FY2022 (+162.4%) and 22.84 million in FY2021 (+23.2%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2018.
  • Year-over-year, Shares Outstanding (Entity) has increased for six consecutive quarters, with growth averaging 15.8% over the last eight quarters.
  • The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q1 2023 (growth of 220.1%), and the weakest in Q4 2024 (a decline of 5.5%).
  • Business Quant data shows TRVI's Shares Outstanding (Entity) at 128.41 million (Q1 2026), 128.31 million (Q4 2025) and 128.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Trevi Therapeutics 2.04 Bn 2.04 Bn - 142.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142.42 Mn
Mar 31, 2026 128.41 Mn
Dec 31, 2025 128.31 Mn
Sep 30, 2025 128.22 Mn
Jun 30, 2025 121.78 Mn
Mar 31, 2025 99.89 Mn
Dec 31, 2024 93.60 Mn
Sep 30, 2024 101.28 Mn
Jun 30, 2024 101.04 Mn
Mar 31, 2024 99.52 Mn
Dec 31, 2023 99.03 Mn
Sep 30, 2023 99.33 Mn
Jun 30, 2023 98.70 Mn
Mar 31, 2023 98.61 Mn
Dec 31, 2022 59.94 Mn
Sep 30, 2022 58.32 Mn
Jun 30, 2022 59.54 Mn
Mar 31, 2022 30.81 Mn
Dec 31, 2021 22.84 Mn
Sep 30, 2021 18.55 Mn
API Access

Trevi Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TRVI&period=max&api_key=YOUR_API_KEY